Hot-Stage Microscopy for Determination of API Particles in a Formulated Tablet
Figure 7
Results of failed bioequivalence study. The maximal concentration in blood () of generic product is out of the tolerance limit. Area under the curve of pharmacokinetic profile (AUC) complies.
